Migden, M. R., Ibrahim, S., Strasswimmer, J., Zeitouni, N., Yoo, S., Seebach, F. A., Lowy, I., Cristea, M. C., Fury, M. G. (2025). Trial in progress: A phase 3 randomized study of low-dose intralesional cemiplimab versus primary surgery for patients with early-stage cutaneous squamous cell carcinoma (CLEAR CSCC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps9612